Patent details

LUC00049 Product Name: Atezolizumab

Basic Information

Publication number:
LUC00049
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP009593948
Legal Status:
Expired
Application number:
LUC00049
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
17/08/2023
SPC Extension Agent Name:
ARONOVA S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
05/06/2024
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/17/1220
Marketing Authorization Type:
Marketing Authorization Date:
25/09/2017
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
17/11/2017
First Marketing Authorization date:
25/09/2017
Grant date:
23/01/2018
Activation date:
23/08/2020
Publication date:
17/11/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
23/08/2025
SPC Extension Expiration:
23/02/2026
Rejection date:
Withdrawal date:

Owner

From:
17/11/2017
 
 

Name:
Dana-Farber Cancer Institute Inc.
Address:
450 Brookline Avenue, Boston, MA 02215, United States (US)

Name:
Genetics Institute LLC
Address:
87 Cambridge Park Drive, Cambridge, MA 02140, United States (US)

Agent

Name:
ARONOVA S.A.
From:
17/11/2017
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2018/01
Publication date:
15/01/2018
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2018/03
Publication date:
20/02/2018
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
SPC3
Bulletin edition number:
2020/10
Publication date:
04/09/2020
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

4

Bulletin Heading:
SPCX1
Bulletin edition number:
2023/10
Publication date:
04/09/2023
Description:
Section G : Applications for extensions for pediatric use – I1E publication

5

Bulletin Heading:
SPCX2
Bulletin edition number:
2024/09
Publication date:
11/07/2024
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
30/07/2024
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
05/06/2024 Publication 1
05/06/2024 Certificate 1
06/06/2024 Outgoing Correspondence 1
17/08/2023 Application Form 4
17/08/2023 Paediatric investigation plan 1
17/08/2023 Summary of the product caracteristics 115
17/08/2023 Marketing authorization 3
17/08/2023 MA publication 1
17/08/2023 Paediatric investigation plan 10
17/08/2023 FNET_DC_FRONTPAGE 1
17/08/2023 Publication 1
17/08/2023 Outgoing Correspondence 1
23/01/2018 Certificate 1
17/11/2017 Publication 1
23/01/2018 Publication 1
17/11/2017 Outgoing Correspondence 1